TRIB1 and cancer: The knockdown of TRIB1 resulted in the downregulation of the key cancer stem cell promoting transcription factors and the resensitisation of the cancer stem cells to cisplatin [44], confirming the importance of elevated TRIB1 expression in the development of the drug-resistant cancer stem cells.